Comparison between Inventurus Knowledge IPO and Sai Life Sciences IPO.
Inventurus Knowledge IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sai Life Sciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Inventurus Knowledge IPO is up to ₹2,497.92 Cr whereas the issue size of the Sai Life Sciences IPO is up to ₹3,042.62 Cr. The final issue price of Inventurus Knowledge IPO is ₹1,329.00 per share and of Sai Life Sciences IPO is ₹549.00 per share.
| Inventurus Knowledge IPO | Sai Life Sciences IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹1 per share |
| Issue Price (Lower) | ₹1,265.00 per share | ₹522.00 per share |
| Issue Price (Upper) | ₹1,329.00 per share | ₹549.00 per share |
| Issue Price (Final) | ₹1,329.00 per share | ₹549.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 11 shares | 27 shares |
| Fresh Issue Size | 0 shares | 1,73,04,189 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹950.00 Cr |
| OFS Issue Size | 1,87,95,510 shares | 3,81,16,934 shares |
| OFS Issue Size (Amount) | up to ₹2,497.92 Cr | up to ₹2,092.62 Cr |
| Issue Size Total | 1,87,95,510 shares | 5,54,21,123 shares |
| Issue Size Total (Amount) | up to ₹2,497.92 Cr | up to ₹3,042.62 Cr |
Inventurus Knowledge IPO opens on Dec 12, 2024, while Sai Life Sciences IPO opens on Dec 11, 2024. The closing date of Inventurus Knowledge IPO and Sai Life Sciences IPO is Dec 16, 2024, and Dec 13, 2024, respectively.
| Inventurus Knowledge IPO | Sai Life Sciences IPO | |
|---|---|---|
| Anchor Bid Date | Dec 11, 2024 | Dec 10, 2024 |
| Issue Open | Dec 12, 2024 | Dec 11, 2024 |
| Issue Close | Dec 16, 2024 | Dec 13, 2024 |
| Basis Of Allotment (Tentative) | Dec 17, 2024 | Dec 16, 2024 |
| Initiation of Refunds (Tentative) | Dec 18, 2024 | Dec 17, 2024 |
| Credit of Share (Tentative) | Dec 18, 2024 | Dec 17, 2024 |
| Listing date (Tentative) | Dec 19, 2024 | Dec 18, 2024 |
| Anchor Lockin End date 1 | Jan 16, 2025 | Jan 14, 2025 |
| Anchor Lockin End date 2 | Mar 17, 2025 | Mar 15, 2025 |
Inventurus Knowledge IPO P/E ratio is 61.55, as compared to Sai Life Sciences IPO P/E ratio of 126.42.
| Inventurus Knowledge IPO | Sai Life Sciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 67.66 | 41.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 63.72 | 35.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 61.55 | 126.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹22802.07 Cr. | ₹11418.63 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 32% | 11.79% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 31.56% | 15.96% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | -0.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹21.59 | ₹4.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 32% | 8.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Inventurus Knowledge IPO Retail Individual Investors (RII) are offered 18,73,050 shares while in Sai Life Sciences IPO retail investors are offered 18,73,050 shares. Qualified Institutional Buyers (QIB) are offered 56,19,154 shares in Inventurus Knowledge IPO and 1,10,84,224 shares in Sai Life Sciences IPO.
| Inventurus Knowledge IPO | Sai Life Sciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 84,28,730 shares | 1,66,26,336 shares |
| Market Maker Reservation | ||
| QIB | 56,19,154 shares | 1,10,84,224 shares |
| NII | 28,09,576 shares | 83,13,169 shares |
| RII | 18,73,050 shares | 1,93,97,394 shares |
| Employee | 65,000 shares | |
| Others | ||
| Total | 1,87,95,510 shares | 5,54,21,123 shares |
Inventurus Knowledge IPO subscribed 52.68x in total, whereas Sai Life Sciences IPO subscribed 10.27x.
| Inventurus Knowledge IPO | Sai Life Sciences IPO | |
|---|---|---|
| QIB (times) | 80.64x | 29.78x |
| NII (times) | 23.25x | 4.99x |
| Big NII (times) | 24.99x | 6.10x |
| Small NII (times) | 19.77x | 2.78x |
| RII (times) | 14.55x | 1.39x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 52.68x | 10.27x |
